Poster Discussion The authors are requested to be available for discussion at their posters on Saturday, May 15, 2004 (2. Obergeschoss)

 

11:45 – 13:30 Poster Session I

Vorsitz/Chair: T. Glück, R. Wagner, Regensburg

Herpes Virus Infections: Poster 11 – Poster 16

Diagnostic Tests: Poster 21 – Poster 23

HIV and Other Retrovirus Infections: Poster 30 – Poster 60

 

11:45 – 13:15 Poster Session II

Vorsitz/Chair: G. Fätkenheuer, U. Wieland, Köln

Respiratory Virus Infections: Poster 1 – Poster 4

Viral Hepatitis: Poster 61 – Poster 70

Case Reports and Miscellaneous: Poster 81 – Poster 95

 

Respiratory Virus Infections

(1) Detection of respiratory syncytial virus and human metapneumovirus

by RT-PCR and real-time PCR

Moya-Suri V, Bruns R, Zimmermann K, Mentel R, Gürtler L

(2) Monitoring the kinetics of a vaccine-induced T-cell response after influenza vaccination

Sester M, Gärtner BC, Kuhlmann MK, Sester U, Köhler H

(3) Characterization of human metapneumoviruses isolated during the winter season 2002/2003 in Germany

Huck B, Sasmaz G, Krempl C, Puppe W, Neumann-Haefelin D, Ari S,

Walther S, Weigl J, Falcone V

(4) Influenza vaccination among physicians is associated with better knowledge and lower anticipation of side effects

Ehrenstein B, Bitter S, Glck T, Salzberger B

 

Herpes Virus Infections

(11) Is the combined analysis of HHV-8 specific humoral and cellular immune responses as a more accurate measure to assign the individual HHV-8 status?

Gärtner BC, Lönard B, Sester U, Mueller-Lantzsch N, Pees H, Sester W,

Köhler H

(12) Implications for pathogenesis: post-translational control of Epstein-Barr virus lytic cycle gene BZLF1 is hampered by mutations in a strain isolated from a case of chronic active infection

Jäger M, Knig U, Niller HH, Larcher C, Huemer H, Mitterer M, Wolf H,

Schwarzmann F

(13) Fast emergence of ganciclovir-resistant cytomegalovirus in solid organ transplant-recipients: advantage of UL97 genotyping versus phenotyping for therapy monitoring

Michel D, Mertens Th

(14) Human herpesvirus type 8 in HIV-infected patients with interstitial pneumonitis

Mller A, Klussmann P, Ftkenheuer G, Salzberger B, Franzen C

(15) Avidity determination of cytomegalovirus immunoglobulin G antibodies by a recombinant immunoblot

Jauris C, Herre U, Schubert J, Arnim B v, Weissbrich B

(16) Detection of herpesvirus DNA in cerebrospinal fluid by real time PCR and correlation with clinical symptoms

Plentz A, Jilg W, Kochanowski B, Ibach B, Drobnik-Dorner A, Knll A

Diagnostic Tests

(21) Rapid laboratory diagnosis in an outbreak of Ebola haemorrhagic fever, Rep. of Congo 2003

Lucht A, Mller P, Becker S, Grunow R, Götz M, Feldmann H, Campbell

P, Wittmann T, Catherine C, Bataboukila P, Yaba P, Formenty P

(22) The EU Invitro Diagnostic Directive, a weapon of mass destruction

Tedder RS

(23) Induction of MHC class-I and -II restricted epitope presentation by urea-adjuvated BZLF1 protein: a novel technology for the detection of protein-specific cytotoxic T-cells

Barabas S, Bauer T, Bauer B, Pllmann K, Wagner R, Jilg W, Wolf H, Deml L

 

HIV and Other Retrovirus Infections

(30) Vaccination status and practice of vaccination recommendations in the Regensburg HIV cohort

Schneidewind A, Audebert F, Kstler J, Glck T, Salzberger B

(31) Radiology of pulmonary manifestations in patients with HIV infection at the time of highly active antiretroviral therapy (HAART)

Schmidt GP, Becker-Gaab C, Bogner JR, Sing A, Reiser MF

(32) Analysis of reverse transcriptase activity in infected and noninfected cell culture supernatants and plasma

Uhlenhaut C, Pauli G, Ellerbrok H

(33) Vigorous HIV specific CD8 T cell responses in late stage HIV infection

Draenert R, Verrill CL, Tang Y, Allen TM, Wurcel A, Rathod A, Addo

MM, Walker BD

(34) Progressive multifokale Leukoenzephalopathie bei AIDS unter Cidofovir

Reichelt D, Grneberg U, Heese C, Akova-tztrk E, Evers S, Husstedt IW

(35) Plasma viral load and CD4+ predict mortality in HIV-2 infected patients and should be used to guide treatment

Hansmann A, Schim van der Loeff M, Kaye S, Aveika A, Whittle H

(36) Multicentric Castleman’s disease in HIV-infected patients: a clinical and histopathological analysis of 10 cases

Schmid H, Zietz C, Ihrler S, Goebel FD, Bogner JR

(37) The long-term influence of intra- and/or peripartal antiretroviral prophylaxis on HIV-exposed not HIV-infected children

Engelhorn C, Strotmann G, Buchholz B, Dunsch D, Neubert J, Vetsi Th,

Notheis G, Belohradsky BH, Wintergerst U

(38) Requests to a HIV drug-drug interaction hotline do not focusing on antiretroviral drugs but on problems concerning co-medication

Meemken L, Lorenzen T, Graefe K, Meyer P, v. Krosigk A, Stoehr A, Plettenberg A

(39) The detection of HIV viral load comparing the Roche Cobas Amplicor and Roche Cobas TaqMan™ Analyzer

Hower M, Lebert R, Mros K, Schlottmann R, Alp S, Banasch M, Hochdorfer

B, Brockmeyer N, Baier JE, Schmidt WE

(40) Use of tenofovir DF (TDF) in salvage patients following structured treatment interruptions

Ulmer A, Mueller M, Frietsch F

(41) Alterations of haematological parameters in HIV-1 infected persons after initiation of highly active antiretroviral therapy (HAART)

Wyen C, Schmeisser N, Lehmann C, Ftkenheuer G

(42) Epidemiology and prognosis of severe end-organ CMV-disease in the HAART and pre-HAART eras

Hartmann P, Fatkenheuer G, Wohrmann A, Uyanek B, Salzberger B

(43) Amino acid changes in the HIV-1/gp41 HR1 region associated with ongoing viral replication selected by T-20 (enfuvirtide) therapy

Eberle J, Goebel FD, Postel N, Jger H, Wienecke R, Bogner JR

(44) Development of drug resistance in intermittent antiretroviral therapy and mother-to-child-transmission (MTCT) prevention in Southern India

Plentz A, Eberle J, Jacob M, Salzberger B, Jilg W, Samuel NM

(45) HPLC detection method for the analysis of uridine in human serum in HIV patients under HAART

Zilly M, Langmann P, Winzer R, Benesic A, Schirmer D, Walker UA, Klinker H

(46) Immunogenicity and safety of a MVA-BN-Nef vaccine in HIV-1 negative volunteers

Harrer T, Schmitt-Haendle M, Chaplin P, Petzold B, Bergmann S,

Hamacher M, Eismann K, Spriewald B, Kalden JR, Willbold D, Harrer E

(47) Analysis of Nef-specific T-cells, viral rebound and autologous viral sequences during structured treatment interruption after therapeutic vaccination with a MVA-BN-Nef vaccine in HIV-1 infected patients

Harrer T, Bauerle M, Ferstl B, Chaplin P, Petzold B, Bergmann S,

Hamacher M, Eismann K, Spriewald B, Kalden JR, Harrer E

(48) Immunogenicity studies of GMP grade HIV-1 clade C CN54 DNA candidate vaccines for human phase I trials in a Balb/c mouse model

Wild J, Bieler K, Deml L, Notka F, Wolf H, Wagner R

(49) The effect of low virus dose exposure on HIV-1 vaccine efficacy in rhesus macaques

Bieler K, Kstler J, Mooij P, Knoop C, Nieuwenhuis I, Bogers W, ten Haaft P, Niphuis H, Koornstra W, Doms R, Fiorelli V, Cafaro A, Ensoli B, Heeney J, Wagner R

(50) Human immunodeficiency virus type-1 (HIV-1) Pr55gag virus-like particles: a potent activator of innate and acquired immune responses

Deml L, Wild J, Speth C, Dierich M, Wolf H, Wagner R

(51) Enhanced expression of gp120/C3d fusion proteins as a basis for induction of high affinity, broadly cross neutralizing HIV-specific antibodies

Wanninger V, Bieler K, Notka F, Graf M, Wild J, Jeffs S, Wagner R

(52) Recombinant chemokines as natural adjuvant of innovative HIVvaccines

Bauer A, Notka F, Graf M, Wild J, Wagner R

(53) Intranasal immunization with a recombinant equine herpesvirus (EHV) type induces HIV-1 Gag specific humoral and cell mediated immune responses

Hofmann H, Köstler J, Wild J, v. Einem J, Trapp S, Osterrieder N, Wagner R

(54) Significant decrease of serum lactate levels after switch to tenofovir

Claas GJ, Bogner JR, Goebel FD

(55) Plasma lactate kinetics after switch from stavudine to tenofovir

Ondrejka S, Bauer AM, Bogner JR

 

Viral Hepatitis

(61) Hepatitis B reactivation during immunosuppressive therapy for haematopoietic stem cell and solid organ transplantation: a prospective study of 37 patients with presumably resolved HBV infection

Knöll A, Kreuzpaintner B, Kreuzpaintner E, Jilg W

(62) Seroepidemiology of GB virus-C/hepatitis G, hepatitis B and hepatitis C virus infection in intravenous drug users in southern Bavaria

Wächtler M, Peterreins K, Backmund M, Hofmann A, Nitschko H, Schraut W, Frösner G

(63) Immune response after hepatitis A vaccination; results of the European VAQTQ(R) Recall

Jaeger G, Campe H, Nitschko H, Kuter B, Harzer E, Koszinowski U

(64) Hepatitis B vaccination of infants born to HIV-infected mothers

Feiterna-Sperling C, Casteleyn S, Kleinkauf N, Grosch-Wrner I

(65) Genotypic and epidemiologic characteristics of hepatitis C virus infection among intravenous drug addicts in southern Bavaria

Wchtler M, Quadflieg C, Backmund M, Roggendorf M, Ross S

(66) Iron regulates hepatitis C virus translation via stimulation of eIF3 expression

Theurl I, Zoller H, Obrist P, Datz C, Bachmann F, Elliott RM, Weiss G

(67) Pegylated interferon alpha 2b (PEG INF) plus ribavirin (RBV) for treatment of chronic hepatitis C in HIV-coinfected patients in a German multicenter trial

Voigt E, Schulz C, Mauss S, Klausen G, Goelz J, Schranz D, Mosthaf FA, Rockstroh JK

(68) In vitro replication of a lamivudine-resistant hepatitis B virus isolate with mutations within the core-promoter region

Boehm S, Tausch UC, Roehrl E, Thasler WE, Schlitt HJ, Weiss T, Jilg W

(69) Immune responses induced by a novel adjuvanted hepatitis B vaccine in individuals who underwent liver transplantation

Bauer T, Deml L, Guenther M, Bienzle U, Jilg W

(70) Regulated and liver specific expression of IFNgamma blocks hepatitis B virus replication

Dumortier J, Oberwinkler H, Schönig K, Bujard H, Giese T, Protzer U

 

Case Reports and Miscellaneous

(81) 2 years of experience – training course: management of patients with highly contagious diseases

Steffen T

(82) Impact of parvovirus B19 infection in immunocompromised patients: case report and screening of blood and blood products for parvoviral DNA

Plentz A, Hahn J, Holler E, Knöll A, Jilg W, Modrow S

(83) Quantification of lytic viral mRNAs for monitoring of Epstein-Barr virus (EBV) reactivation in patients after bone-marrow or renal transplantation

Bauer B, Plentz A, Jilg W

(84) Evaluation of a rapid in vitro assay for the direct and qualitative detection of adenovirus in conjunctival swabs Truchsess I, Scheibenzuber M, Schtzl HM

(85) Detection of polyomavirus BK and JC in children with kidney diseases and after renal transplantation

Mller A, Beck B, Theilemann K, Michalk D, Franzen C, Hoppe B

(86) Epidemiologic studies of prevalence and characterization of TT-virus in different tissues of the birth canal

Egerer R, Langner R, Zell R, Seewald H-J, Stelzner A

(87) A janitor with fever and a macular-papular rash after an insect bite

Presterl E, Stoiser B, Guber S, Graninger W

(88) Unusual primary EBV infection in a 73-year-old woman

Prebeck S, Wopfner F, Seebach J, Mhlau M, Schtzl HM

(89) Epidemiology and clinical aspects of hantavirus infections in Underfranconia

Tollmann F, Schubert J, Weissbrich B

(90) A case of benign recurrent aseptic meningitis

Kandel K, Seiberl G, Pichler H

(91) Detection of vaccinia-specific antibodies in the German population

Obermeier M, Nitschko H, Chaplin P, Mateo L, Jäger G

(92) Novel prophylactic and therapeutic approaches against prion

infections

Gilch S, Ertmer A, Wopfner F, Schätzl HM

(93) Towards vaccination approaches against prion infections

Wopfner F, Schulz G, Gilch S, Schätzl HM

(94) The tyrosine kinase inhibitor STI571 induces cellular clearance of PrPSc in prion-infected cells

Ertmer A, Gilch S, Yun S-W, Flechsig E, Klebl B, Stein-Gerlach M,

Klein MA, Schätzl HM

(95) Prion diseases: from molecular biology to intervention strategies

Nunziante M, Gilch S, Schätzl HM